• Regulatory Services in Malaysia

    Overview

    Steadily growing economy along with the increasing demand for quality medicinal products and medical devices in Malaysia attracts foreign manufactures across the globe to invest in the region. To do so, manufacturers must get the market authorizations from the Ministry of Health. While the Drug Control Authority (DCA) oversees the pharmaceutical registrations in the region, the Malaysian Medical Devices Authority (MDA) regulates medical device registrations.

  • Regulatory Services in Indonesia

    Overview

    With steadily growing healthcare market, Indonesia offers excellent business opportunities for foreign medicinal products and medical device manufacturers. Under the authority of Indonesian Ministry of Health (MOH), the Indonesian National Agency of Drug and Food Control (Badan Pengawas Obat dan Makanan - BPOM) oversees the regulations for medicines and medical devices in the region. To get the market access, manufacturers must navigate through the complex regulatory procedures that range from regulatory requirements, registration procedures and market authorizations.

  • Regulatory Services in Vietnam

    Overview

    The increasing demands for quality healthcare and the rapidly emerging economic sector presents Vietnam as a beneficial market for foreign Drug or Device manufacturers. All medicinal products to be imported into the region requires approval from the Ministry of Health (MOH) and the Drug Administration of Vietnam (DAV) while medical devices are regulated by the Department of Medical Equipment and Health Works (DMEHW). Communicating with different internal regulatory bodies might pose a challenge for foreign manufacturers who are new to Vietnamese Regulatory system.

  • Regulatory Services in Thailand

    Overview

    The growing number of foreign Pharma companies in Thailand coupled with the trend of regional harmonization forecasts a better business growth for the foreign imports of pharmaceutical products, devices, cosmetics, etc. Prior to importing or manufacturing in Thailand, manufacturers must obtain approval from the Food and Drug Administration of Thailand (Thai FDA). With the agency eyeing on the revised versions of regulations, anytime soon, foreign manufacturers might fall short of required Regulatory knowledge on new procedures necessary for market access.

  • Regulatory Services in Hong Kong

    Overview

    With a dual system (Public & Private) in healthcare and with the current profitable scenario of Pharma manufacturing, Hong Kong offers best deal of growth opportunities for foreign medicine and medical device manufacturers, to enter the region. While the Department of Health (DoH) takes control of drug registration and imports/exports, the Medical Device Control Office (MDCO) supervises the medical device’s regulatory requirements.

  • Regulatory Services in Singapore

    Overview

    Due to its central location in Asia, Singapore offers potential growth opportunities for Medical Devices, Pharmaceuticals, Cosmetics and Food Supplements manufacturers across the globe. The Health Sciences Authority (HSA) under the purview of Ministry of Health (MOH) regulates all the procedures. Though the Regulatory system in the region believed to be industry-friendly, it’s constantly evolving regulatory frameworks and registration & licensing procedures might pose a great challenge for manufacturers to keep pace with the standards.

  • Regulatory Services in China

    Overview

    As part of the business expansion plan for medicinal products and medical devices, China offers enormous business opportunities as the Regulatory bodies in the region are being harmonized with that of the international standards. To get the market access, manufacturers must obtain approvals from National Medical Products Administration (NMPA) (formerly known as China Food and Drug Administration [CFDA]). However, the more the processes are being harmonized the stringent and complex they are becoming.